Yanaba, K., Komura, K., Kodera, M., Matsushita, T., Hasegawa, M., Takehara, K., & Sato, S. (2006). Serum levels of monocyte chemotactic protein‐3/CCL7 are raised in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis. BMJ Group.

Yanaba, K., K. Komura, M. Kodera, T. Matsushita, M. Hasegawa, K. Takehara, a S. Sato. Serum Levels of Monocyte Chemotactic Protein‐3/CCL7 Are Raised in Patients With Systemic Sclerosis: Association With Extent of Skin Sclerosis and Severity of Pulmonary Fibrosis. BMJ Group, 2006.

Yanaba, K., et al. Serum Levels of Monocyte Chemotactic Protein‐3/CCL7 Are Raised in Patients With Systemic Sclerosis: Association With Extent of Skin Sclerosis and Severity of Pulmonary Fibrosis. BMJ Group, 2006.